رسالة جامعية
Carga de enfermedad por hipertensión arterial en afiliados a Cajacopi EPS, 2019
| العنوان: | Carga de enfermedad por hipertensión arterial en afiliados a Cajacopi EPS, 2019 |
|---|---|
| المؤلفون: | Lasprilla Fawcett, Silvana Edith, Molina Vargas, María Silvia |
| المساهمون: | Alvis-Guzmán, Nelson, Beltrán, Tulia, Ortíz Ibañez, Luis, Garizabalo, Claudia |
| بيانات النشر: | Corporación Universidad de la Costa Ciencias Empresariales Barranquilla, Colombia Maestría en Gestión de Servicios de Salud |
| سنة النشر: | 2022 |
| المجموعة: | REDICUC - Repositorio Universidad de La Costa |
| مصطلحات موضوعية: | Arterial hypertension, Burden disease, Prevalence, Mortality, AVISA, AVD, AVPP, Hipertensión arterial, Carga de enfermedad, Mortalidad, Prevalencia |
| الوصف: | Objective: Estimate the arterial hypertension burden of CAJACOPI EPS affiliates during 2019. Materials and methods: A descriptive study. The Individual Health Service Provision Records (RIPS), the Social Protection Information System (SISPRO) data cubes and the Capitation Payment Unit (UPC) sufficiency files, were processed. It was analyzed the percentage distribution of cases, as well as age-adjusted rates and burden indicators: It was analyzed the percentage distribution of cases, as well as age-adjusted rates and burden indicators: Years of Life Lost due to Premature Death (AVPP), Years of Life with Disabilty (AVD) and Life Lost Years due to disability (AVISA). Results: In 2019, 8.3% of patients received corresponded to arterial hypertension. The estimated prevalence in patients over 20 years old was 12.7%. From 2012 to 2019, 876 members died due to hypertension, with age-adjusted rates per-100,000, ranging from 10.42 to 15.96. The patients of AVPP were 8791.82, AVD: 13298.49 and AVISA: 25865.24. Differences were found to each indicator by department. Conclusion: A high burden of hypertensive diseases was found in affiliates of CAJACOPI EPS; the results are comparable with official data from the ASIS. The methodological limitations are inherent to the type of study, but the results obtained are considered an important input for decision making. ; Objetivo: Estimar la carga de hipertensión arterial de los afiliados a CAJACOPI EPS durante 2019. Materiales y métodos: Estudio descriptivo. Se procesaron los Registros Individuales de Prestación de servicios de salud (RIPS), los cubos de datos del Sistema de Información de la Protección Social (SISPRO) y los archivos de suficiencia de la Unidad de Pago por Capitación (UPC). Se analiza la distribución porcentual de los casos, así como las tasas ajustadas por edad e indicadores de carga: AVPP, AVD y AVISA. Resultados: En 2019, 8,3% de las atenciones recibidas correspondieron a hipertensión arterial. La prevalencia estimada en mayores de 20 años fue de 12,7%. De 2012 a ... |
| نوع الوثيقة: | master thesis |
| وصف الملف: | 74 Páginas; application/pdf |
| اللغة: | Spanish; Castilian |
| العلاقة: | Acosta Ramírez, N., Peñaloza, R. E., & Rodríguez García, J. (2008). Carga de enfermedad Colombia 2005: Resultados alcanzados. Documento Técnico ASS/1502-08. Bogotá: Pontificia Universidad Javeriana. Centro de Proyectos Para El Desarrollo (CENDEX), 94.; Agudelo C. (2009). Prioridades de investigación en salud en Colombia. Perspectivas de los investigadores. Revista Salud Pública, 53(S2), 301–309.; Allen L, Cobiac L, T. N. (2017). Quantifying the global distribution of premature mortality from non-communicable diseases. Journal of Public Health, 39(4), 698–703.; Alvis, N., & Valenzuela, M. T. (2010). Los QALYs y DALYs como indicadores sintéticos de salud. Revista Médica de Chile, 138, 83–87.; Asamblea Nacional Constituyente. (1991). Constitución Política de Colombia.; Baingana F, B. E. (2006). Changing patterns of disease and mortality in Sub-Saharan Africa: an overview, in Disease and Mortality in Sub-Saharan Africa (World Bank, Ed.).; Banco Mundial. (2019). Esperanza de vida al nacer, mujeres (años) - Colombia. Retrieved from https://datos.bancomundial.org/indicator/SP.DYN.LE00.FE.IN?locations=COTest; Bobadilla J. (2007). Investigación sobre la determinación de prioridades en materia de salud. (F. M. para la Salud, Ed.). México.; Bundy J, Mills K, Chen J, Li C, Greenland P, H. J. (2018). Estimating the association of the 2017 and 2014 hypertension guidelines with cardiovascular events and deaths in US Adults: an analysis of national data. JAMA Cardiology, 3(7), 572–581.; Bundy J, H. J. (2016). Hypertension and related cardiovascular disease burden in China. Annals of Global Health, 82(2), 227–233.; Castañeda Carlos, Vargas Gina, Díaz Diana, Castillo Liliana, Valencia Carlos, C. C. (2015). No Title. In Ínstituto Nacional de Salud (Ed.), Carga de enfermedad por enfermedades crónicas no transmisibles y discapacidad en Colombia (pp. 20–23). Retrieved from https://www.ins.gov.co/Direcciones/ONS/DocumentosTest Marco de implementacin/Metodología de Análisis ONS 2015.pdf; Chow C, Teo K, Rangarajan S, Islam S, Gupta R, Avezum A, Y. S. (2013). Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA, 310(9), 959–968.; Congreso de la República. (2015). Diario Oficial No. 49.427. Ley estatutaria 1751 de 2015. Bogotá.; Cuenta de Alto Costo. (2021). Indicadores de Gestión del Riesgo: ERC 2020. Retrieved July 23, 2021, from https://cuentadealtocosto.org/site/higia/erc-indicadoresaseguramientoTest/; Del Pinto R, F. C. (2019). Hypertension Management at Older Age: An Update. High Blood Pressure & Cardiovascular Prevention, 26(1), 27–36.; Delgado A. (2001). Salud y género en las consultas de atención primaria. Aten Primaria, 27(1), 75–78.; Dempsey M. (1947). Decline in tuberculosis: death rate fails to tell entire story. Am Rey Tuberc, 5(1), 157–164.; Fernández C, Cueto I, G. M. (2020). ENE. Diferencias de Carga En El Cuidado Asociadas Al Género, 14(1), 1–14.; Forouzanfar M, Liu P, Roth G, Ng M, Biryukov S, Marczak L, M. C. (2017). Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990-2015. Jama, 317(2), 165–182.; GBD 2013 Mortality and Causes of Death Collaborators. (2014). Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: A systematic analysis for the global burden of disease study 2013. The Lancet, 385(9963), 117–171.; Gheorghe A, Griffiths U, Murphy A, Legido-Quigley, H, Lamptey P, P. P. (2018). The economic burden of cardiovascular disease and hypertension in low-and middleincome countries: a systematic review. BMC Public Health, 18(1), 1–11.; Gheorghe A, Griffiths U, Murphy A, Legido-Quigley H, Lamptey P, P. P. (2018). The economic burden of cardiovascular disease and hypertension in low-and middleincome countries: a systematic review. BMC Public Health, 18(1), 1–11.; Gómez H. (2011). La Carga de Enfermedad en países de América Latina. Revista de Salud Pública, 53(S2), 172–177.; Gómez L, Mora M, Riascos S, P. D. (2019). Prevalence of diabetes and hypertension in Colombia: A systematic review. Revista Facultad Nacional de Salud Pública, 37(1), 87–95.; Hermida R, Ayala D, Fernandez J, Mojon A, S. M. (2018). Hypertension: New perspective on its definition and clinical management by bedtime therapy substantially reduces cardiovascular disease risk. European Journal of Clinical Investigation, 48(5), e12909.; Ibrahim M, D. A. (2012). Hypertension in developing countries. The Lancet, 380(9841), 611–619.; Jesús Rodríguez-García; Rolando E. Peñaloza-Quintero; Jeannette L. Amaya-Lara. (2017). Estimación de la carga global de enfermedad en Colombia 2012: nuevos aspectos metodológicos. Revista de Salud Pública, 19(2), 235–240.; Johnson, C. O., Nguyen, M., Roth, G. A., Nichols, E., Alam, T., Abate, D., … Murray, C. J. L. (2019). Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology, 18(5), 439–458. https://doi.org/10.1016/S1474-4422Test(19)30034-1; Kearney P, Whelton M, Reynolds K, Muntner P, Whelton P, H. J. (2005). Global burden of hypertension: analysis of worldwide data. The Lancet, 365(9455), 217–223.; Khatib R, McKee M, Shannon H, Chow C, Rangarajan S, Teo K, P. S. I. (2016). Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data. The Lancet, 387(10013), 61–69.; López A. (2006). La Carga de Enfermedad (O. U. Press, Ed.). New York.; Mills K, Bundy J, Kelly T, Reed J, Kearney P, Reynolds K, H. J. (2016). Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation, 134(6), 441–450.; Mills K, Stefanescu A, H. J. (2020). The global epidemiology of hypertension. Nature Reviews Nephrology, 16(4), 223–237.; Ministerio de Salud. (1994). Diario Oficial N° 41.443. Decreto 1485 de 1994. Bogotá.; Ministerio de Salud, D. de E. y D. (2020). Análisis de Situación de Salud (ASIS) Colombia, 2020. Retrieved from https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/ED/PSP/asis2020-colombia.pdfTest; Ministerio de Salud y Protección Social. (2015). Diario oficial N° 49.508. Resolución 1536 de 2015. Bogotá.; Murray, C. J. L., Ezzati, M., Flaxman, A. D., Lim, S., Lozano, R., Michaud, C., … Lopez, A. D. (2012). GBD 2010: Design, definitions, and metrics. The Lancet, 380(9859), 2063–2066. https://doi.org/10.1016/S0140-6736Test(12)61899-6; Murray C, L. A. (1996). The Global Burden of Disease and Injury Series (Cambridge: Harvard School of Public Health, Ed.).; Murray CJL; Acharya AK. (1997). Understanding DALYs. Journal of Health Economics, 16(1), 703–730.; Naghavi M, Abajobir A, Abbafati C, Abbas K, Abd-Allah F, Abera S, F. F. (2017). Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet, 390(10100), 1151–1210.; Nascimento B, Brant L, Yadgir S, Oliveira G, Roth G, Glenn S, R. A. (2020). Trends in prevalence, mortality, and morbidity associated with high systolic blood pressure in Brazil from 1990 to 2017: estimates from the “Global Burden of Disease 2017”(GBD 2017) study. Population Health Metrics, 18(1), 1–22.; Niessen L, Mohan D, Akuoku J, Mirelman A, Ahmed S, Koehlmoos T, P. D. (2018). Tackling socioeconomic inequalities and non-communicable diseases in lowincome and middle-income countries under the Sustainable Development agenda. The Lancet, 391(10134), 2036–2046.; ONS, O. N. de S. (2015). Informe Técnico; Carga de enfermedades por Enfermedades Crónicax No Transmisibles y Discapacidad en Colombia. https://doi.org/http://www.ins.gov.co/lineas-deaccion/ons/SiteAssets/Paginas/publicaciones/5to%20Informe%20ONS%20v-f1.pdfTest; Organización Mundial de La Salud. (n.d.). Macroeconomia y Salud: actualización.; Piao X, Tsugawa S, Takemura Y, Ichikawa N, Kida R, Kunie K, & Managi, S. (2021). Disability weights measurement for 17 diseases in Japan: A survey based on medical professionals. Economic Analysis and Policy, 70(1), 238–248.; Rahman Z, Alam M, J. I. (2021). ssociation of Hypertension and Coronary Heart Diseases. KYAMC Journal, 12(1), 44–47.; Rodríguez J, Peñaloza R, A. J. (2017). Estimación de la carga global de enfermedad en Colombia 2012: nuevos aspectos metodológicos. Revista de Salud Pública, 19(1), 235–240.; Roth G, Nguyen G, Forouzanfar M, Mokdad A, Naghavi M, M. C. (2015). Estimates of global and regional premature cardiovascular mortality in 2025. Circulation,132(13), 1270–1282.; Salem H, Hasan D, Eameash A, El-Mageed H, Hasan S, A. R. (2018). Worldwide prevalence of hypertension: A pooled meta-analysis of 1670 studies in 71 countries with 29.5 million participants. Journal of the American College of Cardiology, 71(11S), A1819–A1819.; Song J, Ma Z, Wang J, Chen L, Z. J. (2020). Gender differences in hypertension. Ournal of Cardiovascular Translational Research, 13(1), 47–54.; The Lancet, editors. (2014). Hypertension: an urgent need for global control and prevention. The Lancet, 383(9332), 1861.; Vos T, Abajobir A, Abate K, Abbafati C, Abbas K, Abd-Allah F, C. M. (2017). Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet, 390(10100), 1211–1259.; Wang C, Yuan Y, Z. M. (2020). Association of age of onset of hypertension with cardiovascular diseases and mortality. Journal of the American College of Cardiology, 75(23), 2921–2930.; Wang Z, Chen Z, Zhang L, Wang X, Hao G, Zhang Z, & C. H. S. I. (2018). Status of hypertension in China: results from the China hypertension survey, 2012–2015. Circulation, 137(22), 2344–2356.; Wanneveich M, Jacqmin-Gadda H, Dartigues J, J. P. (2018). Projections of health indicators for chronic disease under a semi-Markov assumption. Theoretical Population Biology, 119(1), 83–90.; Wenger N, Arnold A, B. C. (2020). Hypertension across a woman’s life cycle. Journal of the American College of Cardiology, 71(16), 1797–1813.; Whelton P, Carey R, Aronow W, Casey Jr D, Collins K, Dennison C, W. J. J. (2017). Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American College of Cardiology, 71(19), e127–e248.; World Health Organization. (2013). Global action plan for the prevention and control of noncommunicable diseases 2013–2010 (W. Health & Organization;, Eds.). Geneva.; World Health Organization. (2014). Global status report on noncommunicable diseases 2014 (No. WHO/NM; World Health Organization, Ed.). Geneva.; World Health Organization. (2015). Making choices in health: WHO Guide to Cost Effectiveness analysis (C. J. an-Torres Edejer, T., Baltussen, R., Adam, T., Hutubessy, R., Acharya, A., Evans, D. B., & Murray, Ed.). Geneva, Switzerland.; World Health Organization and World Economic Forum. (2011). Burden to “Best Buys”: Reducing the Economic Impact of Non-Communicable Diseases in Low and Middle-Income Countries (W. E. Forum, Ed.). Geneva.; Yepes F. (2010). Luces y sombras de la reforma de la salud en Colombia: Ley 100 de 1993. Bogotá: IDRC.; Yusuf S, Wood D, Ralston J, R. K. (2015). The World Heart Federation’s vision for worldwide cardiovascular disease prevention. The Lancet, 386(9991), 399–402.; Zurique M, Zurique C, Camacho P, Sánchez M, H. S. (2019). Prevalence of arterial hypertension in Colombia. Systematic review and meta-analysis. Acta Medica Colombiana, 44(4), 20–33.; https://hdl.handle.net/11323/9159Test; Corporación Universidad de la Costa; REDICUC - Repositorio CUC; https://repositorio.cuc.edu.coTest/ |
| الإتاحة: | https://doi.org/10.1016/S1474-4422Test(19)30034-1 https://doi.org/10.1016/S0140-6736Test(12)61899-6 https://hdl.handle.net/11323/9159Test https://repositorio.cuc.edu.coTest/ |
| حقوق: | Atribución-NoComercial-CompartirIgual 4.0 Internacional (CC BY-NC-SA 4.0) ; https://creativecommons.org/licenses/by-nc-sa/4.0Test/ ; info:eu-repo/semantics/openAccess ; http://purl.org/coar/access_right/c_abf2Test |
| رقم الانضمام: | edsbas.6B669B49 |
| قاعدة البيانات: | BASE |
| الوصف غير متاح. |